Interpace Biosciences, Inc. (IDXG) has seen some recent movement in the marketplace and its stock closed at $3.2700 yesterday. Investors are starting to take interest of IDXG as the stock traded as high as $3.2900 and as low as $3.1100 in the last market trading session.
Interpace Biosciences, Inc. (IDXG) average trading volume is 472.55K. However, in the last market trading session Interpace Biosciences, Inc. (IDXG) traded 89,844 shares. First resistance level on IDXG is $7.06. IDXG 50day moving average is $4.5006 and IDXG two hundred day moving average is $5.2358.
Interpace Biosciences, Inc. (IDXG) most current performance has been indicated by the recent movement in IDXG stock. IDXG has performed -45.86% over the past month, IDXG has performed -38.76% over the past quarter and IDXG has shown -59.69% over the past 12 months. Interpace Biosciences, Inc. (IDXG) has a 52 week range of $2.5700 to $11.0000. Interpace Biosciences, Inc. (IDXG) is trading 27.13% from its 52 week low and -70.27% from its 52 week high. Interpace Biosciences, Inc. (IDXG) is showing a 6.30% short float showing the amount short in the float.
IDXG has 4.00M shares outstanding and 3.96M shares in the float. Interpace Biosciences, Inc. (IDXG) currently has a market cap of $12.79M and income of -33.70M. The EPS next quarter for IDXG is -1.48 and projected EPS next year is 58.20%. The market cap of Interpace Biosciences, Inc. (IDXG) at $12.79M signifies how many Investors own shares of IDXG and is calculated off the last price ($3.2700) of IDXG and the amount of shares outstanding (4.00M) with Interpace Biosciences, Inc. (IDXG).
Interpace Biosciences, Inc. (IDXG) has total cash (mrq) of 13.37M, total cash per share (mrq) of 3.31, total debt of IDXG stands at 4.08M and total debt/equity (mrq) is 7.64. . Interpace Biosciences, Inc. (IDXG) operational cash flow (ttm) is -23.12M, IDXG leveraged free cash flow (ttm) is -7.81M.
IDXG is trading -0.20% below (bearish) its SMA20, -32.04% below (bearish) its SMA50 and -42.36% below (bearish) its SMA200.
